For example, TP53 mutations occur in almost all high grade serous ovarian cancers (Integrated genomic analyses of ovarian carcinoma., 2011) and altered TP53 function is known to play a central role in drug resistance in ovarian cancer (Shelling, 1997). Here, TP53 is linked to ovarian serous adenocarcinoma.